Evidence following guidelines: Another COVID-19 paradox.

Heymann, Warren R

Heymann, Warren R.

Heymann WR; Cooper Medical School of Rowan University, Marlton, New Jersey. Electronic address: wrheymann@gmail.com.

J Am Acad Dermatol ; 84(1): 37-38, 2021 01.

Article in English | MEDLINE | ID: covidwho-893975

Subject(s)

COVID-19/prevention & control; Dermatology/standards; Evidence-Based Medicine/standards; Immunotherapy/standards; Skin Diseases/drug therapy; Biological Products/administration & dosage; Biological Products/adverse effects; COVID-19/diagnosis; COVID-19/immunology; COVID-19/virology; Humans; Immunologic Factors/administration & dosage; Immunologic Factors/adverse effects; Immunotherapy/adverse effects; Practice Guidelines as Topic; SARS-CoV-2/immunology; Severity of Illness Index; Skin Diseases/immunology

Keywords

COVID-19; biologics; immunosuppressives

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Diseases / Evidence-Based Medicine / Dermatology / COVID-19 / Immunotherapy Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: J Am Acad Dermatol Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google